About this trial
The goal of this clinical trial is to compare a standard adolescent-only approach to substance use screening, brief intervention, and referral to treatment to a in primary care settings. Primary outcomes (AOD use, co-occurring behavior problems, parent-youth communication about AOD use) and secondary outcomes (adolescent quality of life, therapy attendance) are assessed at screen/initial and 3, 6, 9, and 12 months follow-up.
Eligibility criteria
Qualifiers
Youth aged 12-17 years with a primary caregiver (i.e., parental figure) also in attendance to primary care appointment
Youth and caregiver are fluent in English or Spanish
Youth and caregiver are capable of using audio-assisted informed consent procedures and independently operating a hand-held tablet device
Youth and caregiver are complete routine site AOD risk screening questions prompted during PC visit intake
Disqualifiers
None
Trial design
Treatments tested in this trial
- Standard Screening
- Standard Psychoeducation
- Standard Brief Negotiated Interview (BNI)
- Standard Referral to Treatment (RT)
- Family Screening
- Family Psychoeducation
- Family Brief Negotiated Interview (BNI)
- Family Facilitated Conversation (FC) & Referral to Treatment (RT)
Treatment groups
Sponsors and collaborators
The National Center on Addiction and Substance Abuse at Columbia University
Lead sponsor
Partnership to End Addiction
Sponsor institution
Abt Associates
Collaborator
Northwestern University
Collaborator
UConn Health
Collaborator
Massachusetts General Hospital
Collaborator
Boston Medical Center
Collaborator
Boston Children's Hospital
Collaborator
Columbia University
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator